Delivery Order SPE2DB22D3004-SPE2DB25FPB56

Award Date 1/10/25
Potential Completion Date 1/13/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,525.16, for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.S ML medical products. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $59,797.34, is a Firm Fixed Price Delivery Order for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,143.87, is for the delivery of 4566964401 - ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 17, 2025. This award is not associated with a set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,994.00, is a Firm Fixed Price Delivery Order for the supply of 4567163949 "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,289.73 firm fixed price delivery order is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical for delivering a wide range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,586.44 firm fixed-price delivery order contract is for the supply of "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" medical products. The contract has an ultimate completion date of February 3, 2025. While the original solicitation was not provided, the award indicates that this is part of a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $55,533.78, is a delivery order for the medical product "ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML". The award has an ultimate completion date of January 16, 2025 and is a firm fixed price contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,159.29, is a Firm Fixed Price Delivery Order for the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,128.30, is a delivery order for "ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML" and has a completion date of December 30, 2024. This contract is not associated with a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a $7,020.01 delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The award has an ultimate completion date of August 29, 2024 and a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPB56
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $2,084.34, is for the delivery of ZEPBOUND 10 MG/0.5 ML PEN 0.S ML medical supplies. The contract is a firm fixed-price delivery order with an ultimate completion date of January 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside.

Generated 4/11/25, 11:20 AM